NCT00019097View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1995

Study Completion Date

March 31, 2007

Conditions
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
Interventions
DRUG

autologous tumor cell vaccine

DRUG

keyhole limpet hemocyanin

DRUG

melphalan

DRUG

sargramostim

Trial Locations (3)

20892

Medicine Branch, Bethesda

72205

Arkansas Cancer Research Center, Little Rock

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019097 - Vaccine Therapy in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter